These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
602 related articles for article (PubMed ID: 33285433)
1. Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer. Mariscal Martínez A; Vives Roselló I; Salazar Gómez A; Catanese A; Pérez Molina M; Solà Suarez M; Pascual Miguel I; Blay Aulina L; Ríos Gozálvez C; Julián Ibáñez JF; Rodríguez Martínez P; Martínez Román S; Margelí Vila M; Luna Tomás MA Surg Oncol; 2021 Mar; 36():28-33. PubMed ID: 33285433 [TBL] [Abstract][Full Text] [Related]
2. Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy. Cabıoğlu N; Karanlık H; Yılmaz R; Emiroğlu S; Tükenmez M; Bademler S; Şimşek DH; Kantarcı TR; Yirgin İK; Bayram A; Dursun M World J Surg Oncol; 2024 Jul; 22(1):178. PubMed ID: 38971793 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study. Martínez M; Jiménez S; Guzmán F; Fernández M; Arizaga E; Sanz C Breast J; 2022; 2022():6111907. PubMed ID: 35855102 [TBL] [Abstract][Full Text] [Related]
4. Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2019 Sep; 30():52-57. PubMed ID: 31500785 [TBL] [Abstract][Full Text] [Related]
5. SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study. Baker JL; Haji F; Kusske AM; Fischer CP; Hoyt AC; Thompson CK; Lee MK; Attai D; DiNome ML Breast Cancer Res Treat; 2022 Jan; 191(1):107-114. PubMed ID: 34652548 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer. Simons JM; van Nijnatten TJA; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef C; Sars PRA; Heijmans HJ; van Haaren ERM; Vles WJ; Contant CME; Menke-Pluijmers MBE; Smit LHM; Kelder W; Boskamp M; Koppert LB; Luiten EJT; Smidt ML JAMA Surg; 2022 Nov; 157(11):991-999. PubMed ID: 36069889 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer. Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377 [TBL] [Abstract][Full Text] [Related]
8. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Switalla KM; Boughey JC; Dimitroff K; Yau C; Ladores V; Yu H; Tchou J; Golshan M; Ahrendt G; Postlewait LM; Piltin M; Reyna CR; Matsen CB; Tuttle TM; Wallace AM; Arciero CA; Lee MC; Tseng J; Son J; Rao R; Sauder C; Naik A; Howard-McNatt M; Lancaster R; Norwood P; Esserman LJ; Mukhtar RA Ann Surg Oncol; 2024 Oct; 31(11):7249-7259. PubMed ID: 38995451 [TBL] [Abstract][Full Text] [Related]
9. The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy. Reitsamer R; Peintinger F; Forsthuber E; Sir A Breast; 2021 Jun; 57():113-117. PubMed ID: 33813230 [TBL] [Abstract][Full Text] [Related]
10. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528 [TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457 [TBL] [Abstract][Full Text] [Related]
12. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. Caudle AS; Yang WT; Mittendorf EA; Black DM; Hwang R; Hobbs B; Hunt KK; Krishnamurthy S; Kuerer HM JAMA Surg; 2015 Feb; 150(2):137-43. PubMed ID: 25517573 [TBL] [Abstract][Full Text] [Related]
13. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes. Plecha D; Bai S; Patterson H; Thompson C; Shenk R Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365 [TBL] [Abstract][Full Text] [Related]
14. Axillary management and long-term oncologic outcomes in breast cancer patients with clinical N1 disease treated with neoadjuvant chemotherapy. Sparger CC; Hernandez AE; Rojas KE; Khan K; Halfteck GG; Möller M; Avisar E; Goel N; Crystal JS; Kesmodel SB World J Surg Oncol; 2024 Jul; 22(1):199. PubMed ID: 39075403 [TBL] [Abstract][Full Text] [Related]
15. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes. Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854 [TBL] [Abstract][Full Text] [Related]
16. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy. Montagna G; Mrdutt MM; Sun SX; Hlavin C; Diego EJ; Wong SM; Barrio AV; van den Bruele AB; Cabioglu N; Sevilimedu V; Rosenberger LH; Hwang ES; Ingham A; Papassotiropoulos B; Nguyen-Sträuli BD; Kurzeder C; Aybar DD; Vorburger D; Matlac DM; Ostapenko E; Riedel F; Fitzal F; Meani F; Fick F; Sagasser J; Heil J; Karanlik H; Dedes KJ; Romics L; Banys-Paluchowski M; Muslumanoglu M; Perez MDRC; Díaz MC; Heidinger M; Fehr MK; Reinisch M; Tukenmez M; Maggi N; Rocco N; Ditsch N; Gentilini OD; Paulinelli RR; Zarhi SS; Kuemmel S; Bruzas S; di Lascio S; Parissenti TK; Hoskin TL; Güth U; Ovalle V; Tausch C; Kuerer HM; Caudle AS; Boileau JF; Boughey JC; Kühn T; Morrow M; Weber WP JAMA Oncol; 2024 Jun; 10(6):793-798. PubMed ID: 38662396 [TBL] [Abstract][Full Text] [Related]
17. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer. Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847 [TBL] [Abstract][Full Text] [Related]
18. Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study. Kim EY; Byon WS; Lee KH; Yun JS; Park YL; Park CH; Youn IY; Choi SH; Choi YJ; Kook SH; Do SI World J Surg; 2018 Feb; 42(2):582-589. PubMed ID: 28808843 [TBL] [Abstract][Full Text] [Related]
19. Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trial. Chen X; Lu Z; Wang C; Lyu M; Qiao J; Sun X; Li L; Zhang C; Liu Z Chin Med J (Engl); 2024 Jun; 137(12):1421-1430. PubMed ID: 38557731 [TBL] [Abstract][Full Text] [Related]
20. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer. Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]